USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Allberry B.V.

USPTO PatentsView assignee record - 12 granted patents across 0 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Allberry ranks #22,158 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 0 technology areas.

#22,158
of 49,997 US assignees by volume
2nd percentile
by Innovation Score (12.8/100)
1.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22158 · Foreign Corporation #22,158 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 12 grants
  • MID-PACK #22,158/49,997
  • PHOTO-FINISH Agile Therapeutics
  • CPC-UNK CPC blank
  • INNOV-LOW 12.8/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2024 · 5y
  • BOOK-RICH 8/10 fields

Nearest grant-volume peer: Agile Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Allberry’s 12.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Allberry

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Allberry's Innovation Score is 12.8/100 (2nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Allberry?

Each dot is one of Allberry’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Allberry’s own 1.0 claims/patent is at or below the 14.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Allberry vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 05101520 Granted patents (volume) Avg claims / patent Agile Therapeutics, Inc. - 12, 10.92Agile TherapeuticsAktivax, Inc. - 12, 15.25AktivaxAlastin Skincare, Inc. - 12, 14.58Alastin SkincareAlertEnterprise, Inc. - 12, 16.58AlertenterpriseAllflex Europe - 12, 13.83Allflex EuropeAlpheus Medical, Inc. - 12, 18.33Alpheus MedicalAlpine Corporation - 12, 1.83AlpineAltenloh, Brinck & Co. U.S., Inc. - 12, 14.83Altenloh Brinck &…Allberry B.V. - 12, 1Allberry B V
Allberry vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Allberry's grants concentrate

Allberry B.V. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2020 (5 grants) versus a trough of 3 in 2021. By volume, Allberry sits between Agile Therapeutics, Inc. and Altenloh, Brinck & Co. U.S., Inc..

Allberry's three-year grant acceleration

Allberry B.V. shows 4 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Allberry's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Allberry holds 12 patents at rank #22,200, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Allberry

By rank, the assignees closest to #22,200 in granted patent volume.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Allberry, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (13 here).

Allberry's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

13 2nd percentile higher than 2% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2.533.544.555.5 202020212024 4
USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Allberry B.V. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 5 41.7%
2021 3 25.0%
2024 4 33.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Allberry B.V.'s patent record in context - here's where to go next.

  • Ranked #22,158 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Allberry B.V. against Agile Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 12.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.